Group | Time | TPD(%) | HM(%) | SCAR(%) | LVEF(%) | EDV(mL) | ESV(mL) | SMS | STS |
Experimental group(n=5) | 3rdday | 44.2 ± 7.0 | 23.4 ± 9.0 | 20.8 ± 8.5 | 38.2 ± 18.5 | 51.2 ± 27.4 | 30.4 ± 19.2 | 33.6 ± 14.4 | 20.0 ± 10.0 |
Experimental group(n=5) | 2thweek | 20.6 ± 8.8 | 8.6 ± 8.9 | 11.8 ± 4.5 | 60.4 ± 6.6 | 54.6 ± 21.5 | 23.2 ± 12.3 | 16.0 ± 5.3 | 9.2 ± 2.9 |
Experimental group(n=5) | 4thweek | 19.8 ± 5.0 | 8.0 ± 5.6 | 11.6 ± 4.4 | 55.8 ± 17.1 | 54.2 ± 27.2 | 20.8 ± 13.3 | 18.4 ± 7.4 | 7.0 ± 5.7 |
Experimental group(n=5) | P valuce | <0.05 | <0.05 | <0.05 | <0.05 | >0.05 | >0.05 | >0.05 | >0.05 |
Control group(n=3) | 3rdday | 24.0 ± 12.4 | 9.3 ± 0.5 | 14.0 ± 10.8 | 58.3 ± 9.0 | 42.0 ± 3.5 | 22.6 ± 7.5 | 29.6 ± 20.8 | 16.3 ± 16.1 |
Control group(n=3) | 2thweek | 42.6 ± 16.6 | 17.6 ± 8.5 | 24.6 ± 7.5 | 49.6 ± 8.3 | 57.7 ± 11.9 | 32.3 ± 8.5 | 39.0 ± 25.3 | 22.0 ± 15.8 |
Control group(n=3) | 4thweek | 36.6 ± 11.5 | 11.3 ± 7.3 | 27.0 ± 10.8 | 43.6 ± 6.6 | 63.0 ± 10.8 | 36.0 ± 10.1 | 34.0 ± 18.0 | 16.6 ± 6.8 |
Control group(n=3) | P valuce | > 0.05 | > 0.05 | > 0.05 | < 0.05 | < 0.05 | < 0.05 | > 0.05 | > 0.05 |